CD22-Directed Cytotoxins
- Name
- CD22-Directed Cytotoxins
- Accession Number
- DBCAT005692
- Description
Not Available
- Drugs
Drug Drug Description Moxetumomab pasudotox A CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment. - Drugs & Drug Targets
Drug Target Type Moxetumomab pasudotox B-cell receptor CD22 target Moxetumomab pasudotox Elongation factor 2 target